Preparation Rich in Growth Factors (PRGF) Treatment for Osteoarthritis of the Knee

NCT00728611 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2011-07-12

No results posted yet for this study

Summary

to evaluate the influence of PRGF treatment on patient suffering from OA knee

Conditions

  • Osteoarthritis of the Knee

Interventions

BIOLOGICAL

PRGF

intra auricular injection 6mg

DRUG

hyaluronic acid

20 mg / 2 ml

DRUG

placebo

physiological water 3cc + lidocain 3cc

Sponsors & Collaborators

  • Meir Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2009-02-28
Completion
2009-03-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00728611 on ClinicalTrials.gov